OTCMKTS:CHEOY Cochlear (CHEOY) Stock Price, News & Analysis → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free CHEOY Stock Alerts $106.24 +2.25 (+2.16%) (As of 05/3/2024 08:53 PM ET) Add Compare Share Share Today's Range$106.09▼$106.2550-Day Range$100.90▼$114.5052-Week Range$73.73▼$114.50Volume2,000 shsAverage Volume3,340 shsMarket Capitalization$13.92 billionP/E RatioN/ADividend Yield1.09%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesSEC FilingsShort Interest Get Cochlear alerts: Email Address Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. About Cochlear Stock (OTCMKTS:CHEOY)Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More CHEOY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEOY Stock News HeadlinesMay 2, 2024 | americanbankingnews.comCochlear (OTCMKTS:CHEOY) Stock Price Down 1.5%April 27, 2024 | finance.yahoo.comCochlear (ASX:COH) May Have Issues Allocating Its CapitalMay 6, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...April 3, 2024 | marketwatch.comCochlear's Oticon Implants Acquisition Approved by Australian RegulatorMarch 27, 2024 | afr.comCan a vaccine slow down the Cochlear train?March 20, 2024 | finance.yahoo.comCochlear Ltd's Dividend AnalysisFebruary 28, 2024 | prnewswire.comCochlear calls for action in Washington D.C. ahead of World Hearing DayFebruary 25, 2024 | msn.comCochlear Limited - Depositary Receipt () (CHEOY) Price Target Increased by 11.05% to 94.91May 6, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...February 22, 2024 | prnewswire.comCochlear announces 2024 winners of annual scholarshipsFebruary 19, 2024 | realmoney.thestreet.comCochlear price target raised by A$20 at UBS, here's whyFebruary 19, 2024 | realmoney.thestreet.comCochlear price target raised by A$18 at Morgan Stanley, here's whyFebruary 19, 2024 | afr.comWhat we learnt from Cochlear, Wesptac, Ampol and Bendigo’s resultsFebruary 18, 2024 | markets.businessinsider.comCiti Reaffirms Their Sell Rating on Cochlear Limited (CHEOF)February 18, 2024 | msn.comCochlear's first-half profit up 35pct to $191 millionFebruary 18, 2024 | fool.com.auCochlear share price falls despite 29% dividend boostFebruary 18, 2024 | marketwatch.comCochlear Hoists Dividend on 35% Jump in 1H Profit -- UpdateFebruary 18, 2024 | afr.comCochlear’s big first half delivers best dividend in a decadeFebruary 16, 2024 | finance.yahoo.comCochlear Implant Market to Accumulate a Valuation of USD 4.0 Billion by 2030, Advancing at a 10.36% CAGR | MarketDigitsFebruary 12, 2024 | markets.businessinsider.comMorgans downgrades Cochlear Limited (CHEOF) to a HoldFebruary 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: CSL (CMXHF), Cochlear Limited (CHEOF)February 8, 2024 | afr.comCochlear lifts guidance despite threat of deafness drugsFebruary 7, 2024 | fool.com.auCochlear shares jump 6% on guidance upgradeFebruary 7, 2024 | marketwatch.comCochlear Shares Jump Amid Stronger-Than-Expected Implant SalesFebruary 6, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Incyte (INCY) and Cochlear Limited (OtherCHEOF)January 25, 2024 | finance.yahoo.comGlobal Cochlear Implants Market Report 2024: Market Forecast for 5 Regions and 17+ Countries, Company Profiles of the Top 10+ Major Market PlayersNovember 27, 2023 | msn.comCochlear - ADR (CHEOY) Price Target Increased by 5.45% to 83.47See More Headlines Receive CHEOY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/30 Dividend3/21/2024Dividend Payable4/30/2024Today5/06/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:CHEOY Previous SymbolOTCMKTS:CHEOY CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio2.57 Quick Ratio1.94 Sales & Book Value Annual Sales$1.32 billion Price / Sales10.57 Cash Flow$1.98 per share Price / Cash Flow53.67 Book Value$8.97 per share Price / Book11.84Miscellaneous Outstanding Shares130,990,000Free FloatN/AMarket Cap$13.92 billion OptionableNot Optionable Beta0.92 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 57)MBA, CEO, MD, President & Executive Director Comp: $3.11MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 59)Chief Technology Officer Comp: $1.33MMs. Karen O'DriscollChief Information OfficerMs. Kristina DevonVice President of Investor RelationsMs. Jennifer StevensonVP of Corporate Communications & BrandMr. Dean PhizackleaSenior Vice President of Global Strategic MarketingMs. Jennifer HornerySenior Vice President of Global People & CultureMr. Greg Bodkin BE (Hons)MComm (UNSW), Senior Vice President of Global Supply ChainMr. Anthony BishopPresident of Asia Pacific & Latin AmericaMore ExecutivesKey CompetitorsNeurocrine BiosciencesNASDAQ:NBIXViatrisNASDAQ:VTRSShionogi & Co., Ltd.OTCMKTS:SGIOYSandoz GroupOTCMKTS:SDZNYBeiGeneNASDAQ:BGNEView All Competitors CHEOY Stock Analysis - Frequently Asked Questions Should I buy or sell Cochlear stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cochlear in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" CHEOY shares. View CHEOY analyst ratings or view top-rated stocks. How have CHEOY shares performed in 2024? Cochlear's stock was trading at $101.39 at the start of the year. Since then, CHEOY stock has increased by 4.8% and is now trading at $106.2430. View the best growth stocks for 2024 here. Are investors shorting Cochlear? Cochlear saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 1,200 shares, a decrease of 42.9% from the March 31st total of 2,100 shares. Based on an average daily volume of 6,200 shares, the days-to-cover ratio is currently 0.2 days. View Cochlear's Short Interest. How often does Cochlear pay dividends? What is the dividend yield for Cochlear? Cochlear announced a dividend on Saturday, March 16th. Stockholders of record on Friday, March 22nd will be given a dividend of $0.0336 per share on Tuesday, April 30th. This represents a dividend yield of 1%. The ex-dividend date of this dividend is Thursday, March 21st. Read our dividend analysis for CHEOY. Is Cochlear a good dividend stock? Cochlear (OTCMKTS:CHEOY) pays an annual dividend of $1.16 per share and currently has a dividend yield of 1.10%. Read our dividend analysis for CHEOY. How do I buy shares of Cochlear? Shares of CHEOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CHEOY) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityIs Tesla going out of business?DTI Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
